Cargando…
Does Systemic Chemotherapy Influence Skeletal Growth of Young Osteosarcoma Patients as a Treatment-Related Late Adverse Effect?
The aim of this study was to investigate the influence of systemic chemotherapy on the skeletal growth of young osteosarcoma patients as a treatment-related late adverse effect. We reviewed the height data of 20 osteosarcoma patients (13 males and 7 females) aged ≤18 years. The average (±SD) age at...
Autores principales: | Hoshi, Manabu, Oebisu, Naoto, Iwai, Tadashi, Ban, Yoshitaka, Nakamura, Hiroaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221654/ https://www.ncbi.nlm.nih.gov/pubmed/35735434 http://dx.doi.org/10.3390/curroncol29060325 |
Ejemplares similares
-
Successful pre-operative local control of skin exposure by sarcoma using combination of systemic chemotherapy and Mohs’ chemosurgery
por: Hoshi, Manabu, et al.
Publicado: (2020) -
Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas
por: Iwai, Tadashi, et al.
Publicado: (2022) -
High tartrate-resistant acid phosphatase (TRACP 5b) level in cystic fluid is a significant prognostic marker for postoperative recurrence in solitary bone cysts
por: Hoshi, Manabu, et al.
Publicado: (2022) -
Impact of the COVID-19 pandemic on bone and soft tissue tumor treatment: A single-institution study
por: Ban, Yoshitaka, et al.
Publicado: (2023) -
Anti-Tumor Effect and Neurotoxicity of Ethanol Adjuvant Therapy after Surgery of a Soft Tissue Sarcoma
por: Ban, Yoshitaka, et al.
Publicado: (2023)